Used primarily in pharmaceutical research as an intermediate in the synthesis of biologically active compounds. Its structure supports the development of kinase inhibitors and other targeted therapies in oncology. The compound's nitro and sulfonyl functional groups enhance binding selectivity, making it valuable in designing drugs that require high specificity. It is also employed in the preparation of novel piperazine-based derivatives for evaluation in central nervous system (CNS) disorders due to piperazine's known influence on neurotransmitter receptors. Additionally, it serves as a building block in medicinal chemistry for structure-activity relationship (SAR) studies, helping optimize drug candidates for improved metabolic stability and potency.